Fear of COVID-19 and Physical Activity in Children With Asthma During the Covid Period

NCT ID: NCT05220488

Last Updated: 2022-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-03

Study Completion Date

2022-12-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Social isolation rules applied to prevent and control COVID-19 disease reduce cross-infection, exposure to more allergens in the home environment, reducing hospital admissions by avoiding contamination, asthma control, fear of COVID-19 and physical activity for reasons such as increased anxiety and lack of exercise. How it will affect is unclear. Considering all these, positive or negative changes in asthma-related risk factors, changes in physical activity level, asthma attacks and control, fear of COVID-19 will be examined and contribute to the literature in children with asthma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Social isolation rules applied to prevent and control COVID-19 disease reduce cross-infection, exposure to more allergens in the home environment, reducing hospital admissions by avoiding contamination, asthma control, fear of COVID-19 and physical activity for reasons such as increased anxiety and lack of exercise. How it will affect is unclear. Considering all these, positive or negative changes in asthma-related risk factors, changes in physical activity level, asthma attacks and control, fear of COVID-19 will be examined and contribute to the literature in children with asthma. Therefore, our primary aim in our study is; The aim of this study is to examine the asthma control and COVID-19 fear levels of asthmatic children who were in social isolation during the COVID-19 pandemic in children with asthma and compare their effects compared to healthy children. Our secondary aim in our study; The aim of this study is to examine the physical activity levels of children in social isolation during the COVID-19 pandemic in children with asthma.

Asthma Group Inclusion Criteria:

* Having been diagnosed with asthma,
* In addition, not having any chronic disease,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having mental, neurological, orthopedic, cardiovascular or pulmonary problems that would prevent physical activity,

Asthma Group Exclusion Criteria:

* The presence of a medical indication that requires complete restriction of physical activity,
* To have had COVID-19 in the last 1 month or to be newly diagnosed with COVID-19,
* Having symptoms of COVID-19 and suspected illness,
* Existence of cooperation and communication problems.

Healthy Group Inclusion Criteria

* Not having any chronic disease for healthy individuals,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,

Healthy Group Exclusion Criteria

* The presence of a medical indication that requires complete restriction of physical activity,
* To have had COVID-19 in the last 1 month or to be newly diagnosed with COVID-19,
* Having symptoms of COVID-19 and suspected illness,
* Existence of cooperation and communication problems

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma in Children

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Asthma COVID-19 Physical Activity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Asthma Group

Asthma Group

Assessment

Intervention Type OTHER

Parameters such as physical activity and fear of covid will be evaluated in asthmatic and healthy children and adolescents.

Healthy Group

Healthy Group

Assessment

Intervention Type OTHER

Parameters such as physical activity and fear of covid will be evaluated in asthmatic and healthy children and adolescents.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assessment

Parameters such as physical activity and fear of covid will be evaluated in asthmatic and healthy children and adolescents.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having been diagnosed with asthma,
* In addition, not having any chronic disease,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having mental, neurological, orthopedic, cardiovascular or pulmonary problems that would prevent physical activity,


* Not having any chronic disease for healthy individuals,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,

* Not having any chronic disease for healthy individuals,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,

Exclusion Criteria

* The presence of a medical indication that requires complete restriction of physical activity,
* To have had COVID-19 in the last 1 month or to be newly diagnosed with COVID-19,
* Having symptoms of COVID-19 and suspected illness,
Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bartın Unıversity

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Şeyma Nur Önal

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Şeyma Nur Önal

Role: PRINCIPAL_INVESTIGATOR

Bartın Unıversity

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bartın University

Bartın, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.

Reference Type RESULT
PMID: 32113704 (View on PubMed)

Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol. 2020 Dec;146(6):1295-1301. doi: 10.1016/j.jaci.2020.09.017. Epub 2020 Sep 28.

Reference Type RESULT
PMID: 33002516 (View on PubMed)

Lovinsky-Desir S, Deshpande DR, De A, Murray L, Stingone JA, Chan A, Patel N, Rai N, DiMango E, Milner J, Kattan M. Asthma among hospitalized patients with COVID-19 and related outcomes. J Allergy Clin Immunol. 2020 Nov;146(5):1027-1034.e4. doi: 10.1016/j.jaci.2020.07.026. Epub 2020 Aug 6.

Reference Type RESULT
PMID: 32771560 (View on PubMed)

Barsoum Z. Pediatric Asthma & Coronavirus (COVID-19)-Clinical Presentation in an Asthmatic Child-Case Report. SN Compr Clin Med. 2020;2(6):700-702. doi: 10.1007/s42399-020-00310-3. Epub 2020 May 19.

Reference Type RESULT
PMID: 32838131 (View on PubMed)

Papadopoulos NG, Custovic A, Deschildre A, Mathioudakis AG, Phipatanakul W, Wong G, Xepapadaki P, Agache I, Bacharier L, Bonini M, Castro-Rodriguez JA, Chen Z, Craig T, Ducharme FM, El-Sayed ZA, Feleszko W, Fiocchi A, Garcia-Marcos L, Gern JE, Goh A, Gomez RM, Hamelmann EH, Hedlin G, Hossny EM, Jartti T, Kalayci O, Kaplan A, Konradsen J, Kuna P, Lau S, Le Souef P, Lemanske RF, Makela MJ, Morais-Almeida M, Murray C, Nagaraju K, Namazova-Baranova L, Garcia AN, Yusuf OM, Pitrez PMC, Pohunek P, Pozo Beltran CF, Roberts GC, Valiulis A, Zar HJ; Pediatric Asthma in Real Life Collaborators. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2592-2599.e3. doi: 10.1016/j.jaip.2020.06.001. Epub 2020 Jun 17.

Reference Type RESULT
PMID: 32561497 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COVID-19asthmachildphysicalact

Identifier Type: -

Identifier Source: org_study_id